Your browser doesn't support javascript.
loading
Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
Huri, Hasniza Zaman; Huey, Chua Chew; Mustafa, Norasyikin; Mohamad, Nor Fadhilah; Kamalden, Tengku Ain.
Affiliation
  • Huri, Hasniza Zaman; University of Malaya. Faculty of Medicine. Department of Pharmacy. Kuala Lumpur. MY
  • Huey, Chua Chew; University of Malaya. Faculty of Medicine. Department of Pharmacy. Kuala Lumpur. MY
  • Mustafa, Norasyikin; UiTM. Department of Ophthalmology. Jalan Hospital. Sungai Buloh. MY
  • Mohamad, Nor Fadhilah; University of Malaya. Faculty of Medicine. Department of Ophthalmology. Kuala Lumpur. MY
  • Kamalden, Tengku Ain; University of Malaya. Faculty of Medicine. Department of Ophthalmology. Kuala Lumpur. MY
Braz. J. Pharm. Sci. (Online) ; 54(2): e17484, 2018. tab, graf
Article in English | LILACS | ID: biblio-951942
Responsible library: BR1.1
ABSTRACT
Abstract The risk of having microvascular complication is high among Type 2 Diabetes Mellitus (T2DM) patients. However, factors associated with the glycemic control and progression of diabetic retinopathy (DR) in T2DM patients is limited. This study aims to determine association between anti-diabetic agents, glycemic control and progression of diabetic retinopathy in a Malaysian population. A retrospective study conducted in a tertiary teaching hospital in Malaysia, from January 2009 until March 2014. This study enrolled 104 patients aged 40-84 years, with a mean age 63.12 ± 9.18 years. patients had non-proliferative diabetic retinopathy (NPDR, 77%) and 35% had proliferative diabetic retinopathy (PDR). Diabetic macula edema (DME) was present in 20% of NPDR patients, compared with 7% in PDR. Alpha-glucosidase inhibitor (p=0.012), age (p=0.014) and number of antidiabetic agents used (p=0.015) were significantly associated with stages of diabetic retinopathy. Family history of T2DM (p=0.039) was associated with DME. Identifying factors influencing the progression of diabetic retinopathy may aid in optimizing the therapeutic effects of anti-diabetic agents in T2DM patients.
Subject(s)


Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: LILACS Main subject: Diabetes Mellitus, Type 2 / Diabetic Retinopathy Type of study: Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Aged, 80 and over / Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Braz. J. Pharm. Sci. (Online) Journal subject: Farmacologia / Terapˆutica / Toxicologia Year: 2018 Document type: Article / Project document Affiliation country: Malaysia Institution/Affiliation country: UiTM/MY / University of Malaya/MY

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: LILACS Main subject: Diabetes Mellitus, Type 2 / Diabetic Retinopathy Type of study: Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Aged, 80 and over / Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Braz. J. Pharm. Sci. (Online) Journal subject: Farmacologia / Terapˆutica / Toxicologia Year: 2018 Document type: Article / Project document Affiliation country: Malaysia Institution/Affiliation country: UiTM/MY / University of Malaya/MY
...